{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:26:51Z","timestamp":1788251211805,"version":"build-2803163510"},"reference-count":85,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,8,27]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) is one of the leading non-AIDS-defining causes of death among HIV-positive (HIV+) individuals. However, the evidence surrounding specific components of CVD risk remains inconclusive. We conducted a systematic review and meta-analysis to synthesise the available evidence and establish the risk of myocardial infarction (MI) among HIV+ compared with uninfected individuals. We also examined MI risk within subgroups of HIV+ individuals according to exposure to combination antiretroviral therapy (ART), ART class\/regimen, CD4 cell count and plasma viral load (pVL) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews until 18 July 2018. Furthermore, we scanned recent HIV conference abstracts (CROI, IAS\/AIDS) and bibliographies of relevant articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Original studies published after December 1999 and reporting comparative data relating to the rate of MI among HIV+ individuals were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two reviewers working in duplicate, independently extracted data. Data were pooled using random-effects meta-analysis and reported as relative risk (RR) with 95% CI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-two of the 8130 identified records were included in the review. The pooled RR suggests that HIV+ individuals have a greater risk of MI compared with uninfected individuals (RR: 1.73; 95%\u2009CI 1.44 to 2.08). Depending on risk stratification, there was moderate variation according to ART uptake (RR, ART-treated=1.80; 95%\u2009CI 1.17 to 2.77; ART-untreated HIV+ individuals: 1.25; 95%\u2009CI 0.93 to 1.67, both relative to uninfected individuals). We found low CD4 count, high pVL and certain ART characteristics including cumulative ART exposure, any\/cumulative use of protease inhibitors as a class, and exposure to specific ART drugs (eg, abacavir) to be importantly associated with a greater MI risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicate that HIV infection, low CD4, high pVL, cumulative ART use in general including certain exposure to specific ART class\/regimen are associated with increased risk of MI. The association with cumulative ART may be an index of the duration of HIV infection with its attendant inflammation, and not entirely the effect of cumulative exposure to ART per se.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42014012977.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-025874","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:49:13Z","timestamp":1569325753000},"page":"e025874","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":74,"title":["Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-1076","authenticated-orcid":false,"given":"Oghenowede","family":"Eyawo","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Faculty of Health, York University, Toronto, ON, Canada"},{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenyth","family":"Brockman","sequence":"additional","affiliation":[{"name":"George & Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Department of Occupational Science and Occupational Therapy, Faculty of Medicine, University of British Columbia, Burnaby, British Columbia, Canada"},{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Hull","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Lear","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"Healthy Heart Program, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bennett","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Guillemi","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrado","family":"Franco-Villalobos","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Adam","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3120-9694","authenticated-orcid":false,"given":"Edward J","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio S G","family":"Montaner","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Hogg","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"},{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"2025121523592922000_9.9.e025874.1","doi-asserted-by":"publisher","DOI":"10.1086\/652283"},{"key":"2025121523592922000_9.9.e025874.2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"The Lancet"},{"key":"2025121523592922000_9.9.e025874.3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"Hiv infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025121523592922000_9.9.e025874.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000352"},{"key":"2025121523592922000_9.9.e025874.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030218"},{"key":"2025121523592922000_9.9.e025874.6","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311210-00010"},{"key":"2025121523592922000_9.9.e025874.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062744"},{"key":"2025121523592922000_9.9.e025874.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00751.x"},{"key":"2025121523592922000_9.9.e025874.9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830fe35e"},{"key":"2025121523592922000_9.9.e025874.10","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31815e7251"},{"key":"2025121523592922000_9.9.e025874.11","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.197"},{"key":"2025121523592922000_9.9.e025874.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir269"},{"key":"2025121523592922000_9.9.e025874.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60423-7"},{"key":"2025121523592922000_9.9.e025874.14","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31819ff0e6"},{"key":"2025121523592922000_9.9.e025874.15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq244"},{"key":"2025121523592922000_9.9.e025874.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059551","article-title":"Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review","volume":"8","author":"Bavinger","year":"2013","journal-title":"PLoS One"},{"key":"2025121523592922000_9.9.e025874.17","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31826f993c"},{"key":"2025121523592922000_9.9.e025874.18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328349c6ee"},{"key":"2025121523592922000_9.9.e025874.19","doi-asserted-by":"crossref","unstructured":"Shah ASV , Stelzle D , Lee KK , et al . Global burden of atherosclerotic cardiovascular disease in people living with the human immunodeficiency virus: a systematic review and meta-analysis. Circulation 2018","DOI":"10.1161\/CIRCULATIONAHA.117.033369"},{"key":"2025121523592922000_9.9.e025874.20","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med"},{"key":"2025121523592922000_9.9.e025874.21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/hiv.12043","article-title":"HIV and cardiovascular disease: comment on Islam et\u2009al","volume":"14","author":"Neaton","year":"2013","journal-title":"HIV Med"},{"key":"2025121523592922000_9.9.e025874.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00265.x"},{"key":"2025121523592922000_9.9.e025874.23","doi-asserted-by":"publisher","DOI":"10.1086\/655144"},{"key":"2025121523592922000_9.9.e025874.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328347fa16"},{"key":"2025121523592922000_9.9.e025874.25","first-page":"193","article-title":"Re-assessing the cardiovascular risk of abacavir in the Swiss HIV Cohort Study (SHCS) using a flexible marginal structural model [ICPE Abstract 396]. In: Abstracts of the 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management","volume":"22","author":"Klein","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025121523592922000_9.9.e025874.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht409"},{"key":"2025121523592922000_9.9.e025874.27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2025121523592922000_9.9.e025874.28","unstructured":"Eyawo O , Brockman G , Lear S , et al . Risk of cardiovascular disease events among HIV-positive individuals compared to HIV-negative individuals: a systematic review and meta-analysis (number: CRD42014012977). Inte Prospect Regist Syst Rev 2014."},{"key":"2025121523592922000_9.9.e025874.29","unstructured":"Wells GA , Shea B , O'Connell D , et al . The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2018. Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed 17 January 2019]."},{"key":"2025121523592922000_9.9.e025874.30","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2025121523592922000_9.9.e025874.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00443-2"},{"key":"2025121523592922000_9.9.e025874.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5980","article-title":"Hazards and hazard ratios","volume":"345","author":"Sedgwick","year":"2012","journal-title":"BMJ"},{"key":"2025121523592922000_9.9.e025874.33","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c1ea43"},{"key":"2025121523592922000_9.9.e025874.34","doi-asserted-by":"crossref","unstructured":"McCullagh P , Nelder JA . Chapter 13: models for survival data. In: McCullagh P , Nelder JA , eds. Generalized linear models. 2nd ed. London, New York: Chapman & Hall\/CRC, 1989: 419\u201331.","DOI":"10.1007\/978-1-4899-3242-6_13"},{"key":"2025121523592922000_9.9.e025874.35","doi-asserted-by":"publisher","DOI":"10.2307\/2287816"},{"key":"2025121523592922000_9.9.e025874.36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00043764-198106000-00013","article-title":"Practical considerations for approximating relative risk by the standardized mortality ratio","volume":"23","author":"Symons","year":"1981","journal-title":"J Occup Environ Med"},{"key":"2025121523592922000_9.9.e025874.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019490","article-title":"Premenstrual syndrome and alcohol consumption: a systematic review and meta-analysis","volume":"8","author":"Fern\u00e1ndez","year":"2018","journal-title":"BMJ Open"},{"key":"2025121523592922000_9.9.e025874.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.12.016"},{"key":"2025121523592922000_9.9.e025874.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-015-0007-2","article-title":"A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer\u2019s disease in older adults","volume":"15","author":"Beckett","year":"2015","journal-title":"BMC Geriatr"},{"key":"2025121523592922000_9.9.e025874.40","first-page":"59","article-title":"Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis","volume":"45","author":"Bateson","year":"2016","journal-title":"Aust Fam Physician"},{"key":"2025121523592922000_9.9.e025874.41","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025121523592922000_9.9.e025874.42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population","volume":"75","author":"Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121523592922000_9.9.e025874.43","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328339192f"},{"key":"2025121523592922000_9.9.e025874.44","doi-asserted-by":"crossref","unstructured":"Mills EJ , Jansen JP , Kanters S . Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer. JAMA 2015;313.doi:10.1001\/jama.2014.16482","DOI":"10.1001\/jama.2014.16482"},{"key":"2025121523592922000_9.9.e025874.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121523592922000_9.9.e025874.46","unstructured":"Higgins J , Green S . Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]: The Cochrane Collaboration,, 2011. Available: http:\/\/www.cochrane.org\/handbook [Accessed 27 July 2017]."},{"key":"2025121523592922000_9.9.e025874.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025121523592922000_9.9.e025874.48","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060410"},{"key":"2025121523592922000_9.9.e025874.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7568.597"},{"key":"2025121523592922000_9.9.e025874.50","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i11"},{"key":"2025121523592922000_9.9.e025874.51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis489"},{"key":"2025121523592922000_9.9.e025874.52","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31821d33a5"},{"key":"2025121523592922000_9.9.e025874.53","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0588-4","article-title":"Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? a cohort collaboration","volume":"14","author":"Sabin","year":"2016","journal-title":"BMC Med"},{"key":"2025121523592922000_9.9.e025874.54","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw564"},{"key":"2025121523592922000_9.9.e025874.55","first-page":"335","article-title":"Abacavir use and risk for myocardial infarction in the NA-ACCORD [CROI Abstract 749LB]. In Special Issue: Abstracts From the 2015 Conference on Retroviruses and Opportunistic Infections","volume":"23","author":"Palella","year":"2015","journal-title":"Top Antivir Med"},{"key":"2025121523592922000_9.9.e025874.56","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"The Lancet HIV"},{"key":"2025121523592922000_9.9.e025874.57","article-title":"Lower CD4 count and higher viral load are associated with increased risk of myocardial infarction [CROI abstract 739]. In Special Issue: Abstracts From the 2014 Conference on Retroviruses and Opportunistic Infections","volume":"22","author":"Drozd","year":"2014","journal-title":"Top Antivir Med"},{"key":"2025121523592922000_9.9.e025874.58","doi-asserted-by":"publisher","DOI":"10.1086\/649897"},{"key":"2025121523592922000_9.9.e025874.59","doi-asserted-by":"publisher","DOI":"10.1086\/528862"},{"key":"2025121523592922000_9.9.e025874.60","doi-asserted-by":"publisher","DOI":"10.1086\/518285"},{"key":"2025121523592922000_9.9.e025874.61","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"The Lancet"},{"key":"2025121523592922000_9.9.e025874.62","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study","volume":"5","author":"Rickerts","year":"2000","journal-title":"Eur J Med Res"},{"key":"2025121523592922000_9.9.e025874.63","unstructured":"Carman WJ , Bowlin S , McAfee AT . Human immunodeficiency (HIV) therapy and cardiovascular (CV) events [ICPE Abstract 323]. In: Abstracts from the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Pharmacoepidemiol Drug Saf 2011;20."},{"key":"2025121523592922000_9.9.e025874.64","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/QAD.0000000000001594","article-title":"Cardiovascular outcomes among HIV-infected veterans receiving atazanavir","volume":"31","author":"LaFleur","year":"2017","journal-title":"AIDS"},{"key":"2025121523592922000_9.9.e025874.65","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw061","article-title":"Risk of cardiovascular events among patients initiating efavirenz-containing versus Efavirenz-Free antiretroviral regimens","volume":"3","author":"Rosenblatt","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2025121523592922000_9.9.e025874.66","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1827-1","article-title":"Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study","volume":"16","author":"Rosenblatt","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025121523592922000_9.9.e025874.67","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ316"},{"key":"2025121523592922000_9.9.e025874.68","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181f4b752"},{"key":"2025121523592922000_9.9.e025874.69","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181a9992c"},{"key":"2025121523592922000_9.9.e025874.70","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247115.81832.a1"},{"key":"2025121523592922000_9.9.e025874.71","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ014"},{"key":"2025121523592922000_9.9.e025874.72","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000009"},{"key":"2025121523592922000_9.9.e025874.73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"2025121523592922000_9.9.e025874.74","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis201"},{"key":"2025121523592922000_9.9.e025874.75","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open Heart"},{"key":"2025121523592922000_9.9.e025874.76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2190"},{"key":"2025121523592922000_9.9.e025874.77","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328337afdf"},{"key":"2025121523592922000_9.9.e025874.78","doi-asserted-by":"publisher","DOI":"10.1086\/644769"},{"key":"2025121523592922000_9.9.e025874.79","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0000000000001547","article-title":"Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation","volume":"31","author":"Alvarez","year":"2017","journal-title":"AIDS"},{"key":"2025121523592922000_9.9.e025874.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.05.015"},{"key":"2025121523592922000_9.9.e025874.81","doi-asserted-by":"publisher","DOI":"10.1089\/088922203766774487"},{"key":"2025121523592922000_9.9.e025874.82","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu010"},{"key":"2025121523592922000_9.9.e025874.83","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu869"},{"key":"2025121523592922000_9.9.e025874.84","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12007"},{"key":"2025121523592922000_9.9.e025874.85","doi-asserted-by":"publisher","DOI":"10.1037\/\/1082-989X.3.4.486"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-025874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:59:42Z","timestamp":1765871982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-025874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,24]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bmjopen-2018-025874"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-025874","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}